Voxelotor, which was sold under the brand name Oxbryta, was suddenly pulled from the market over safety concerns from clinical trials outside the U.S.
6 months ago
This July 2019 image provided by the Sarah Cannon Research Institute shows Victoria Gray on her infusion day during a gene editing trial for sickle cell disease at the Sarah Cannon Research Institute and The Children's Hospital At TriStar Centennial in Nashville. Since her treatment, Gray has weaned herself from pain medications she depended on to manage her symptoms. (Anthem Pictures/Sarah Cannon Research Institute via AP)